• Home
  • A-B index
  • Pharmacological Index
  • Drug Classes
  • Active Ingredients
  • Companies
  • News
  • Dutasteride Taro
    / Taro


    Active Ingredient
    Dutasteride 0.5 mg

    Status in Israel
    RX

    Presentation and Status in Health Basket

    Presentation Basket Yarpa Pharmasoft

    Soft Capsules

    30 X 0.5 mg

    full basket chart 35081

    Dosage

    The usual dose is generally one capsule (0.5 mg) taken once a day.


    Indications

    Treatment of moderate to severe symptoms of benign prostatic hyperplasia (BPH). Reduction in the risk of acute urinary retention (AUR) and surgery in patients with moderate to severe symptoms of BPH.


    Contra-Indications

    Women and children and adolescents.
    Patients with known hypersensitivity to dutasteride, other 5-alpha reductase inhibitors, or any component of the preparation.
    Patients with severe hepatic impairment.


    Special Precautions

    Please refer to the license holder for further details.


    Side Effects

    Please refer to the license holder for further details.


    Drug interactions

    Please refer to the license holder for further details.


    Pregnancy and Lactation

    Please refer to the license holder for further details.


    Overdose

    Please refer to the license holder for further details.


    Manufacturer
    Laboratorios Leon Farma SA, Spain
    CLOSE